Aripiprazole; Acute schizophrenia episode; positive symptoms
Showing 1 - 25 of >10,000
Schizophrenia, Schizotypal Disorder, Delusional Disorder Trial in Munich (Metacognitive and Defusion Training)
Active, not recruiting
- Schizophrenia
- +12 more
- Metacognitive and Defusion Training
-
Munich, Bavaria, GermanyMax Planck Institute of Psychiatry
Aug 23, 2022
Schizophrenia, Schizoaffective Disorder, Schizotypal Disorder Trial in Worldwide (SUCCEED Community-Based Intervention)
Recruiting
- Schizophrenia
- +10 more
- SUCCEED Community-Based Intervention
-
Blantyre, Southern, Malawi
- +3 more
Aug 17, 2023
Schizophrenia, Treatment-resistant Schizophrenia, Side Effect Trial (Aripiprazole, Paliperidone)
Not yet recruiting
- Schizophrenia
- +6 more
- (no location specified)
Sep 27, 2023
Resistant Schizophrenia From the Illness Onset
Not yet recruiting
- Treatment-resistant Schizophrenia
- risperidone, olanzapine, aripiprazole
- (no location specified)
Nov 7, 2023
Difference in the Change in Cardiovascular Risk in Treatment Resistant Schizophrenia Trial (Aripiprazole 10 MG)
Not yet recruiting
- Difference in the Change in Cardiovascular Risk in Treatment Resistant Schizophrenia
- Aripiprazole 10 MG
- (no location specified)
Mar 10, 2023
Schizophrenia, Schizoaffective Disorder, Depressive Type, Schizophreniform Disorder Trial in Los Angeles (Aripiprazole Lauroxil,
Recruiting
- Schizophrenia
- +2 more
- Aripiprazole Lauroxil
- +2 more
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Aug 16, 2021
Schizophrenia Trial in Miami (Aripiprazole Lauroxil, Computerized cognitive and functional skills training)
Not yet recruiting
- Schizophrenia
- Aripiprazole Lauroxil
- Computerized cognitive and functional skills training
-
Miami, FloridaJackson Memorial Hospital
Dec 14, 2022
Schizophrenia, Negative Symptoms in Schizophrenia Trial in Shanghai (Agomelatine)
Recruiting
- Schizophrenia
- Negative Symptoms in Schizophrenia
-
Shanghai, ChinaShanghai Mental Health Center
Dec 9, 2022
Striatal Connectivity and Clinical Outcome in Psychosis
Recruiting
- Psychotic Disorders
- Risperidone or Aripiprazole (patients only)
-
Glen Oaks, New YorkZucker Hillside Hospital
Jan 24, 2022
Schizophrenia and Related Disorders Trial in Douliu, Yunlin (Repetitive Transcranial Magnetic Stimulation)
Recruiting
- Schizophrenia and Related Disorders
- Repetitive Transcranial Magnetic Stimulation
-
Douliu, Yunlin, TaiwanDepartment of Psychiatry, National Taiwan University Hospital Yu
Jan 2, 2023
Negative Symptoms in Schizophrenia Trial (Metacognitive Training for Negative Symptoms (MCT), Supportive Counselling)
Not yet recruiting
- Negative Symptoms in Schizophrenia
- Metacognitive Training for Negative Symptoms (MCT)
- Supportive Counselling
- (no location specified)
Nov 6, 2023
Schizophrenia Trial in Xi'an (Brexpiprazole, Aripiprazole)
Completed
- Schizophrenia
-
Xi'an, Shanxi, ChinaNo.15 Yanyin Road, Yanta District
Nov 11, 2021
Schizophrenia Trial in Changsha (transcranial magnetic stimulation, sham stimulation)
Active, not recruiting
- Schizophrenia
- transcranial magnetic stimulation
- sham stimulation
-
Changsha, Hunan, ChinaCentral South University
Nov 16, 2022
Schizophrenia Trial in Seoul (WID-RGC20(Cariprazine) 3mg/day, WID-RGC20(Cariprazine) 6mg/day, Placebo for WID-RGC20(Cariprazine)
Enrolling by invitation
- Schizophrenia
- WID-RGC20(Cariprazine) 3mg/day
- +2 more
-
Seoul, Korea, Republic ofWhan In Pharm.
Dec 8, 2021
Schizophrenia, Schizophrenia; Psychosis Trial in Ukraine, United States (Xanomeline and Trospium Chloride Capsules, Placebo)
Recruiting
- Schizophrenia
- Schizophrenia; Psychosis
- Xanomeline and Trospium Chloride Capsules
- Placebo
-
Bentonville, Arkansas
- +28 more
Aug 12, 2022
Social Phobia, Psychosis Trial in Verdun (Manualized group Cognitive-behavioral therapy (CBT) for social anxiety in first
Completed
- Social Phobia
- Psychosis
- Manualized group Cognitive-behavioral therapy (CBT) for social anxiety in first episode psychosis
- Group Computer assisted cognitive remediation therapy
-
Verdun, Quebec, CanadaDouglas Mental Health University Institute
Oct 21, 2022
Neurophysiologic Biomarkers for Cognitive Rehabilitation
Not yet recruiting
- Schizophrenia Spectrum Disorders
- Neurophysiologic Biomarker Assessments
-
San Diego, CaliforniaVA San Diego Healthcare System, San Diego, CA
Jul 6, 2023
Breakthrough Symptoms With Long-Acting Injectable Medications
Not yet recruiting
- Schizophrenia
- Schizophrenia Relapse
- Second Generation Long-Acting Injectable Antipsychotic Medications
- (no location specified)
Jul 22, 2022
Schizophrenia Trial in Copenhagen (Aripiprazole)
Completed
- Schizophrenia
-
Copenhagen, Glostrup, DenmarkCenter for Neuropsychiatric Schizophrenia Research, University o
Apr 27, 2021
Schizophrenia, Schizoaffective Disorder Trial in Worldwide (RO6889450, Placebo, Risperidone)
Terminated
- Schizophrenia, Schizoaffective Disorder
- RO6889450
- +2 more
-
Little Rock, Arkansas
- +49 more
Jul 14, 2022
Psychosis, Schizophrenia Trial in Zürich (Motivational Interviewing, Supportive conversations)
Recruiting
- Psychosis
- Schizophrenia
- Motivational Interviewing
- Supportive conversations
-
Zürich, SwitzerlandPsychiatric University Hospital Zurich
Jun 9, 2023